Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473680 · ClinicalTrials.gov registry record
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01473680: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01473680 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473680 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study is being done to find out if it is possible to enroll minority women with breast cancer in a study of how chemotherapy may affect their ability to answer certain questions and perform certain tasks that measure brain activity. The investigators want to look at thinking and brain activity in patients to see if cancer treatments can cause any brain changes. For this study, women without cancer, are being asked to participate in order to compare the answers to the questions and the brain wave activity measured in the women with cancer to women who don't have cancer.
Interventions
- OTHER EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473680
The ClinicalTrials.gov registry entry for NCT01473680 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire is the first listed.
NCT01473680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473680 about?
NCT01473680 is a clinical study titled "Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients". This study is being done to find out if it is possible to enroll minority women with breast cancer in a study of how chemotherapy may affect their ability to answer certain questions and perform certain tasks that measure brain activity. The investigators want to look at thinking and brain activity ...
What is the current status of trial NCT01473680?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-11. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01473680?
The interventions under investigation include: EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire (OTHER).
Who is sponsoring clinical trial NCT01473680?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.